Device Week, 19 August 2021 – Big FDA Approvals For Abbott, Zimmer Biomet

In this week’s podcast, Medtech Insight editor Reed Miller provides an overview of Abbott’s Amplatzer Amulet, which was approved by the US FDA for preventing thrombus embolization in patients with nonvalvular atrial fibrillation. Managing editor Marion Webb discusses Zimmer Biomet’s FDA clearance of its Rosa robotic surgery platform for total hip replacement and the intensifying competition in the rising surgical robotics market.

Listen to the podcast via the player below:

 

Open Media

 

The archive of Device Week and the rest of Informa Pharma Intelligence’s podcasts are available on the Informa Pharma Intelligence channel on Apple Podcasts, Google Podcasts, SoundCloud, TuneIn, Spotify Podcasts and via smart speakers if one of these platforms has been set up as your default podcast provider. 

Medtech Insight articles addressing topics discussed in this episode:

• FDA Approves Abbott’s Amplatzer Amulet LAA Occluder To Compete With Boston Scientific’s Watchman

• Zimmer Biomet Receives FDA Nod For Rosa Total Hip System, Intensifying Ortho Robotics Rivalry

• Market Intel: Expanding Applications And Improved Offerings To Drive Robotically Assisted Surgery Market

• Market Intel: Medtechs, Surgeons Embrace ‘Virtual Operating Theater’ As New Reality